TP53 and cancer: There is still poor understanding of whether Sirt1 acts as a tumor promoter through induction of genomic instability in cancers [37,38,39,40,41], possibly through deacetylation and suppression of p53 activity [42,43], and/or modulating the activity of various tumor suppressing proteins in different cancer types, including colon cancer.